Neutropenia Summary

Networked: 11957 relevant articles (730 outcomes, 1206 trials/studies) for this Disease

Key Drugs and Agents for Neutropenia

1. Granulocyte Colony-Stimulating Factor (G-CSF) : 146 outcomes 147 studies in 1468 results : IBA
   
2. Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) : 40 outcomes 57 studies in 342 results : IBA
   
3. Filgrastim (Neupogen) : 39 outcomes 76 studies in 324 results : FDA 2
   
4. Anti-Bacterial Agents (Antibiotics) : 29 outcomes 44 studies in 552 results : IBA
   
5. pegfilgrastim (Neulasta) : 27 outcomes 42 studies in 175 results : FDA 2
   
6. Intercellular Signaling Peptides and Proteins (Growth Factors) : 26 outcomes 22 studies in 225 results : IBA
   
7. docetaxel (Taxotere) : 21 outcomes 47 studies in 363 results : FDA 3
   
8. Colony-Stimulating Factors (Colony Stimulating Factor) : 21 outcomes 36 studies in 248 results : IBA
   
9. Piperacillin : 17 outcomes 31 studies in 93 results : FDA 10 Generic
   
10. Cyclophosphamide (Cytoxan) : 16 outcomes 32 studies in 223 results : FDA 10 Generic
    

Diseases Related to Neutropenia

1. Infection
2. Neoplasms (Cancer)
3. Fever (Fevers)
4. Thrombocytopenia (Thrombopenia)
5. Anemia

Key Therapies for Neutropenia

1. Drug Therapy (Chemotherapy) : 193 outcomes 388 studies in 2755 results
   
2. Bone Marrow Transplantation (Transplantation, Bone Marrow) : 16 outcomes 14 studies in 166 results
   
3. Splenectomy : 8 outcomes in 56 results
   
4. Transplants (Transplant) : 6 outcomes 12 studies in 251 results
   
5. Transplantation (Transplant Recipients) : 6 outcomes 8 studies in 192 results